Science Explorer Back to mapMap
Discussion
Researcher · Gladstone Institutes · United States

Steven M. Finkbeiner

Steven M. Finkbeiner publishes mostly in Molecular Biology, Cellular and Molecular Neuroscience and Neurology, on topics such as Genetic Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis Research and Mitochondrial Function and Pathology.

ORCID 0000-0002-3480-394X OpenAlex
World rank
#29,914
of 7,710,434 ranked researchers
Rank in United States
#11,318
of 1,627,098
Works
315
Citations
48k
Citations per work
151.1
h-index
83
i10-index 173Top 0.6% in Molecular Biology
Steven M. Finkbeiner

What does Steven M. Finkbeiner research?

Steven M. Finkbeiner's work is mostly in Biochemistry, Genetics and Molecular Biology (37%), Medicine (20%), Neuroscience (17%).

Life Sciences: 169 works · 53.7% of their workBiochemistry, Genetics and Molecular Biology: 116 works · 36.7% of their workMolecular Biology: 101 works · 32.0% of their workBiophysics: 15 works · 4.7% of their workNeuroscience: 54 works · 17.0% of their workCellular and Molecular Neuroscience: 54 works · 17.0% of their workEverything else: 84 works · 26.7% of their workHealth Sciences: 62 works · 19.6% of their workMedicine: 62 works · 19.6% of their workNeurology: 41 works · 12.9% of their workPhysiology: 11 works · 3.4% of their workGenetics: 10 works · 3.3% of their workTHEIR WORKSteven M.Finkbeiner315works
Life Sciences54%Health Sciences20%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology11636.7%
    2. Neuroscience5417.0%
  2. Everything else8426.7%
    1. Medicine6219.6%
  1. 1Molecular Biology32% of their works
  2. 2Cellular and Molecular Neuroscience17% of their works
  3. 3Neurology13% of their works
  4. 4Biophysics5% of their works
  5. 5Physiology3% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Steven M. Finkbeiner's research?

The keywords of their largest research topics: Mitochondrial Dysfunction, Neurodegeneration, Oxidative Stress, Huntington's Disease, Protein Aggregation, FUS/TLS, TDP-43 and Mitochondria.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Mitochondrial Dysfunction1413 topics
  2. Neurodegeneration812 topics
  3. Oxidative Stress712 topics
  4. Huntington's Disease701 topic
  5. Protein Aggregation701 topic
  6. FUS/TLS511 topic
  7. TDP-43511 topic
  8. Mitochondria411 topic
  9. Reactive Oxygen Species411 topic
  10. Neurotransmission311 topic
  11. Synaptic Plasticity311 topic
  12. Parkinson's Disease301 topic
  13. a-Synuclein301 topic
  14. Bioimage Analysis251 topic
  15. High-Content Screening251 topic
  16. SMN1231 topic
  17. Spinal Muscular Atrophy231 topic
  18. Alternative Splicing221 topic
  19. RNA-Binding Proteins221 topic

Where does Steven M. Finkbeiner work?

Steven M. Finkbeiner's main affiliation in the publication record is Gladstone Institutes, United States.

How many publications and citations does Steven M. Finkbeiner have?

OpenAlex counts 315 works and 47,598 citations for Steven M. Finkbeiner, an h-index of 83, ranking #29,914 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Steven M. Finkbeiner. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.